Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02225418Not ApplicableWithdrawn

Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy

Role: lead

NCT01993290Not ApplicableCompleted

USG Brachial Plexus Block for Upper Extremity Surgery

Role: lead

NCT01840800Not ApplicableCompleted

USG Nerve Blocks for ACL Reconstruction

Role: lead

NCT01837394Phase 4Completed

Ultrasound-guided Blocks for Ambulatory Knee Arthroscopy

Role: lead

All 4 trials loaded